Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 07, 2022

BUY
$42.05 - $47.77 $69,929 - $79,441
1,663 Added 15.34%
12,507 $544,000
Q1 2022

Apr 05, 2022

SELL
$40.23 - $47.74 $67,787 - $80,441
-1,685 Reduced 13.45%
10,844 $472,000
Q4 2021

Jan 05, 2022

BUY
$38.88 - $45.31 $487,127 - $567,688
12,529 New
12,529 $552,000
Q1 2021

Apr 05, 2021

SELL
$34.27 - $40.01 $332,830 - $388,577
-9,712 Closed
0 $0
Q4 2020

Jan 07, 2021

SELL
$34.07 - $39.94 $1.47 Million - $1.72 Million
-43,142 Reduced 81.62%
9,712 $357,000
Q3 2020

Oct 06, 2020

SELL
$38.11 - $42.99 $150,839 - $170,154
-3,958 Reduced 6.97%
52,854 $1.99 Million
Q2 2020

Jul 06, 2020

SELL
$37.87 - $43.58 $450,047 - $517,904
-11,884 Reduced 17.3%
56,812 $2.32 Million
Q1 2020

Apr 03, 2020

SELL
$32.47 - $48.83 $158,778 - $238,778
-4,890 Reduced 6.65%
68,696 $2.6 Million
Q4 2019

Jan 24, 2020

BUY
$42.0 - $48.25 $226,884 - $260,646
5,402 Added 7.92%
73,586 $3.46 Million
Q3 2019

Oct 03, 2019

BUY
$40.46 - $43.52 $1,456 - $1,566
36 Added 0.05%
68,184 $2.91 Million
Q2 2019

Jul 03, 2019

SELL
$39.4 - $42.7 $45,349 - $49,147
-1,151 Reduced 1.66%
68,148 $2.73 Million
Q1 2019

Apr 03, 2019

BUY
$38.57 - $42.69 $15,350 - $16,990
398 Added 0.58%
69,299 $2.9 Million
Q4 2018

Jan 03, 2019

BUY
$37.8 - $42.69 $43,961 - $49,648
1,163 Added 1.72%
68,901 $2.62 Million
Q3 2018

Oct 03, 2018

BUY
$39.75 - $42.69 $19,119 - $20,533
481 Added 0.72%
67,738 $2.72 Million
Q2 2018

Jul 10, 2018

SELL
$39.61 - $42.76 $81,675 - $88,171
-2,062 Reduced 2.97%
67,257 $2.71 Million
Q1 2018

May 02, 2018

SELL
$36.18 - $40.15 $90,232 - $100,134
-2,494 Reduced 3.47%
69,319 $2.71 Million
Q4 2017

Jan 04, 2018

SELL
$35.34 - $41.9 $122,135 - $144,806
-3,456 Reduced 4.59%
71,813 $2.55 Million
Q3 2017

Oct 04, 2017

BUY
$39.44 - $41.55 $2.97 Million - $3.13 Million
75,269
75,269 $3.06 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Fulton Bank, N.A. Portfolio

Follow Fulton Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.